Addressing primary medication nonadherence through a telephonic intervention from the physicians office was not any more successful than the usual phone calls from the pharmacy.
Addressing primary medication nonadherence (PMN) through a telephonic intervention from the physicians office was not any more successful than the usual phone calls from the pharmacy, according to a study published in the Journal of Managed Care & Specialty Pharmacy.
The researchers focused on medications prescribed for hypertension, hyperlipidemia, asthma, and type 2 diabetes. Patients with medication orders at CVS pharmacies who failed to pick up their prescription after 14 days were enrolled into the program. The 290 patients were split into 2 groups: nurse-call intervention or usual care.
“The patients enrolled in the study were younger, more likely to have asthma, less likely to have hypertension, and more likely to have Medicaid or be self-paying for their care,” the authors explained.
The purpose of the study was to determine whether nonadherent patients were more likely to pick up their medications if a member of their primary care team contacted them.
“Among the patients who were enrolled in the study, medication adherence was very low and was not significantly changed by the telephonic intervention,” the authors wrote.
Of the 142 patients randomized to receive the intervention, only 50 (39%) spoke in person with the outreach nurse, and of those, just 15 (30%) picked up their medications.
Some of the reasons why patients did not pick up their medications included issues with the medication costs and prior problems with medications.
A quarter (25%) of interventions returned to pick up their prescriptions compared with 24% of control patients. Adherence was not significantly affected by the telephonic intervention, the researchers discovered.
“The lack of effect of the intervention shows that PMN among those patients who have not picked up a new prescription may be difficult to change, perhaps requiring interventions that move beyond telephone outreach to reconnect patients with their primary care providers who prescribed the medication,” the authors concluded.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen